Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis”

• Meron Teklu, MD,
• Hye Jin Chung, MD, MMSc

Affiliations

Meron Teklu, MD

Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Harvard Combined Dermatology Residency, Boston, Massachusetts

Hye Jin Chung, MD, MMSc

Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Correspondence to: Hye Jin Chung, MD, MMSc, Beth Israel Deaconess Medical Center, Department of Dermatology, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02115